Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Hokuto Corporation ( (JP:1379) ) has provided an update.
Hokuto Corporation, in partnership with Riken Vitamin Co., Ltd., has developed a new mushroom extract from unused parts and off-grade bunashimeji mushrooms, for which they were granted a patent in November 2024. This innovation, which supports sustainable production, is already being used in Riken Vitamin’s products, with plans for broader application. This development marks a significant advancement in utilizing natural resources efficiently, reinforcing both companies’ commitment to sustainability and health-oriented products.
More about Hokuto Corporation
Hokuto Corporation is a prominent Japanese company specializing in mushroom research, development, production, and sales. It is one of Japan’s largest comprehensive mushroom corporate groups with operations that extend internationally. The company focuses on leveraging natural materials for sustainable production and has a strong collaborative relationship with Riken Vitamin Co., Ltd., known for its food, improving agents, and health care products.
YTD Price Performance: 2.61%
Average Trading Volume: 73,247
Technical Sentiment Consensus Rating: Strong Sell
Current Market Cap: Yen58.3B
Find detailed analytics on 1379 stock on TipRanks’ Stock Analysis page.